Best Shipping Companies To Watch In Right Now

Morgan Stanley’s�Kimberly Greenberger and�Duo Li�explain why they declared�Macy’s�(M) a Best Idea:

Getty Images�

Consistent execution, clear EPS growth algorithm, sector-leading FCF yield and shareholder returns deserve a higher FY2 P/E multiple than 12x…

On a PEG ratio basis, Macy’s is the cheapest stock in our Softlines/Department Store coverage universe, other than Michael Kors�(KORS). We think M�� consistent execution, compelling strategies and strong management deserves a higher multiple. Raising our base case P/E multiple 1 turn and our FY15 EPSe 10c to $5.10, 5c above consensus. Our new $66 PT is 13x our FY15 EPSe.

Not only that, but Macy’s is also kicking butt in online too.

Macy’s also has the largest online sales in our coverage universe. Over the last 5 years, Macy’s has spent $1.8B in IT/eComm initiatives, more than any other company we cover. Ship-from-store allows Macy’s to allocate fashion and brands to smaller volume stores without adding markdown risk. While in-store pickup and return reduce shipping cost and drive incremental traffic. These are just two of many examples of Macy’s sector-leading omni channel capabilities. We think these initiatives will be difficult for competitors to replicate, given the financial resources and talent required.

Hot Companies To Buy Right Now: athenahealth Inc.(ATHN)

athenahealth, Inc., a business services company, provides ongoing billing, clinical-related, and other related services to medical group practices primarily in the United States. It provides services through the athenaNet, a proprietary Internet-based practice management application. The company primarily offers athenaCollector, a revenue cycle management service that automates and manages billing-related functions for physician practices, and includes a practice management platform. The athenaCollector assists its physician clients with the handling of claims and billing processes to help manage reimbursement. The company also provides Anodyne Analytics, a business intelligence application, which provides physicians and practice managers with insight into practice performance. In addition, it offers athenaClinicals, an electronic health record service that automates and manages medical-record-management-related functions for physician practices, as well as assists medical groups with the handling of physician documentation, orders, and related inbound and outbound communications. Further, the company provides athenaCommunicator that allows practices to manage patient communication tasks electronically, including the use of automated reminder calls; the creation of a self-service patient portal for registration, appointment requests, bill payments, and general communication; automatic generation of emails to patients; and patient education tools. It sells its products through a direct sales force, as well as through channel partners. The company was formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. athenahealth, Inc. was incorporated in 1997 and is headquartered in Watertown, Massachusetts.

Advisors' Opinion:

• [By gurujx]

  AthenaHealth, Inc. (ATHN): Director David Eric Robinson sold 60,000 Shares

  Director David Eric Robinson sold 60,000 shares of ATHN stock on 04/14/2014 at the average price of $140.61. David Eric Robinson owns at least 3,692 shares after this. The price of the stock has increased by 3.53% since.

• [By Monica Gerson]

  athenahealth (NASDAQ: ATHN) is expected to post its Q3 earnings at $0.31 per share on revenue of $154.99 million.

  The Blackstone Group LP (NYSE: BX) is estimated to report its Q3 earnings at $0.55 per share on revenue of $1.25 billion.

• [By Monica Gerson]

  athenahealth (NASDAQ: ATHN) is projected to post its Q1 earnings at $0.17 per share on revenue of $169.99 million.

  Baxter International (NYSE: BAX) is expected to report its Q1 earnings at $1.09 per share on revenue of $3.88 billion.

Best Shipping Companies To Watch In Right Now: Kilroy Realty Corp (KRC)

Kilroy Realty Corporation, incorporated on September 13, 1996, is a self-administered real estate investment trust (REIT). The Company focuses on office and industrial submarkets along the West Coast. The Company owns, develops, acquires and manages real estate assets, consisting primarily of Class A real estate properties in the coastal regions of Los Angeles, Orange County, San Diego County, the San Francisco Bay Area and greater Seattle. As of December 31, 2011, the Company�� portfolio consisted of 104 office buildings (the Office Properties) and 39 industrial buildings (the Industrial Properties). The Company owns its interests in all of its Office Properties and Industrial Properties through the Kilroy Realty, L.P. (the Operating Partnership) and Kilroy Realty Finance Partnership, L.P. (the Finance Partnership). In March 2012, the Company purchased Menlo Corporate Center in Menlo Park, California. In June 2012, the Company purchased two office properties in the Lake Union submarket of Seattle. In January 2013, the Company purchsed Westlake Terry, a two building 320,399 square-foot office property. In September 2013, the Company announced it has completed the purchase of a 13.8 acre Class A office campus in the coastal Del Mar sub-market of San Diego. Effective September 19, 2013, Kilroy Realty Corp acquired The Heights, a owner and operator of an office campus. In January 2014, Kilroy Realty Corp completed the disposition of 13 San Diego office properties in two tranches. In January 2014, Kilroy Realty Corp acquired from The Academy of Motion Pictures Arts and Sciences an approximate four-acre parcel near the intersection of Sunset Boulevard and Vine Street in Hollywood.

On January 28, 2011, the Company acquired one building in 250 Brannan Street, San Francisco, CA. On April 21, 2011, the Company acquired four buildings in 10210, 10220 and 10230 NE Points Drive; 3933 Lake Washington Boulevard NE, Kirkland, WA. On May 12, 2011, the Company acquired one building in 10770 Water! idge Circle, San Diego, CA. On June 3, 2011, the Company acquired one building in 601 108th Avenue N.E., Bellevue, WA. On June 9, 2011, the Company acquired one building in 4040 Civic Center Drive, San Rafael, CA. On September 15, 2011, the Company acquired one building in 201 Third Street, San Francisco, CA. On November 15, 2011, the Company acquired one building in 301 Brannan Street, San Francisco, CA. On December 15, 2011, the Company acquired one building in 370 Third Street, San Francisco, CA. In December 2011, it commenced redevelopment at one of its acquired properties in San Francisco. On January 30, 2012, the Company sold 15004 Innovation Drive, San Diego, CA and 10243 Genetic Center Drive, San Diego, CA. In September 2011, the Company disposed of its interest in 10350 Barnes Canyon and 10120 Pacific Heights Drive, San Diego, CA. In December 2011, the Company disposed of interest in 2031 E. Mariposa Avenue, Los Angeles, CA.

The Company conducts substantially all of its operations through the Operating Partnership of which as of December 31, 2011, it owned a 97.2% general partnership interest. Kilroy Realty Finance, Inc., a wholly owned subsidiary of the Company, is the sole general partner of the Finance Partnership. The Company conducts substantially all of its development activities through Kilroy Services, LLC (KSLLC), which is a wholly owned subsidiary of the Operating Partnership. Its wholly owned subsidiaries include Kilroy Realty TRS, Inc., Kilroy Realty Management, L.P., Kilroy RB, LLC, Kilroy RB II, LLC, Kilroy Realty Northside Drive, LLC and Kilroy Realty 303, LLC. As of December 31, 2011, the Company�� tenants included Intuit, Inc., Bridgepoint Education, Inc., Delta Dental of California, AMN Healthcare, Inc., Hewlett-Packard Company, Fish & Richardson P.C., Scripps Health and Epson America, Inc.

Advisors' Opinion:

• [By Ken McGaha]

  The four REITS I reviewed are Kilroy Realty Corp. (KRC), Kimco Realty Corp. (KIM), Eastgroup Properties (EGP) and Federal Realty Investment Trust (FRT).

• [By Rich Duprey]

  Real estate investment trust�Kilroy Realty� (NYSE: KRC  ) �announced yesterday�its second-quarter dividend of $0.35 per share, the same rate it's paid since 2009.

Best Shipping Companies To Watch In Right Now: Consolidated Water Co. Ltd. (CWCO)

Consolidated Water Co. Ltd., through its subsidiaries, develops and operates seawater desalination plants and water distribution systems. It operates through three segments: Retail, Bulk, and Services. The Retail segment produces and supplies water to end-users, including residential, commercial, and government customers, as well as tourist properties. The Bulk segment supplies potable water to government utilities and private customers. The Services segment designs, constructs, and sells desalination plants to third parties, as well as provides desalination plant management and operating services to plants owned by others. The company uses reverse osmosis technology to produce fresh water from seawater. It operates approximately 14 reverse osmosis desalination plants in the Cayman Islands, The Bahamas, Belize, the British Virgin Islands, and the United States. Consolidated Water Co. Ltd. was founded in 1973 and is based in Grand Cayman, the Cayman Islands.

Advisors' Opinion:

• [By Garrett Cook]

  Utilities shares gained around 0.83 percent in today’s trading. Meanwhile, top gainers in the sector included Consolidated Water Co (NASDAQ: CWCO), up 4.3 percent, CenterPoint Energy (NYSE: CNP), up 2.1 percent.

Best Shipping Companies To Watch In Right Now: UTi Worldwide Inc.(UTIW)

UTi Worldwide Inc., through its subsidiaries, operates as a supply chain services and solutions company worldwide. Its supply chain planning and optimization services help its clients in designing and implementing solutions for their supply chains. The company operates in two segments, Freight Forwarding, and Contract Logistics and Distribution. The Freight Forwarding segment offers air and ocean freight forwarding, customs brokerage, and other related services. This segment operates as an indirect carrier for its clients or as an authorized agent for airlines and ocean carriers by providing pick-up and delivery service between the carrier and the location of the shipper or recipient. Its customs brokerage services include preparing and filing formal documentation required for clearance through customs agencies, obtaining customs bonds, facilitating payment of import duties on behalf of the importer, arranging for payment of collect freight charges, assisting with determin ing and obtaining the commodity classifications for shipments, and performing other related services. The Contract Logistics and Distribution segment offers various services, which comprise receiving, deconsolidation and decontainerization, sorting, put away, consolidation, assembly, cargo loading and unloading, assembly of freight and protective packaging, warehousing, order management, and customized distribution and inventory management services, as well as outsourced services, such as inspection services, quality centers, and manufacturing support. This segment also provides various distribution, consultation, outsourced management services, planning and optimization services, coordination of purchase orders, and customized management services. The company serves various industries, such as pharmaceutical, retail, apparel, chemical, automotive, high technology, and electronics industries. The company was founded in 1986 and is headquartered in Road Town, the British Virg in Islands.

Advisors' Opinion:

• [By Monica Gerson]

  UTi Worldwide (NASDAQ: UTIW) is projected to report its Q2 earnings at $0.01 per share on revenue of $1.14 billion. UTi Worldwide shares dropped 0.22% to close at $9.07 yesterday.

• [By Victor Reklaitis]

  UTi Worldwide (UTIW) is expected to post its quarterly results at 8 a.m. Eastern on Monday. Wall Street sees the provider of supply-chain services losing 12 cents per share on revenue of $1.09 billion, according to a FactSet poll of 11 analysts. Shares in UTi are down 36% this year and off 22% over the past 12 months.

• [By Jake L'Ecuyer]

  Top Headline
  UTi Worldwide (NASDAQ: UTIW) reported a wider-than-expected fourth-quarter loss. UTi Worldwide posted a quarterly net loss of $50.7 million, or $0.48 per share, versus a year-ago loss of $142.8 million, or $1.38 per share.

• [By Jake L'Ecuyer]

  Top Headline
  UTi Worldwide (NASDAQ: UTIW) reported a wider-than-expected fourth-quarter loss. UTi Worldwide posted a quarterly net loss of $50.7 million, or $0.48 per share, versus a year-ago loss of $142.8 million, or $1.38 per share.

Best Shipping Companies To Watch In Right Now: Tractebel Energia SA (TBLE3)

Tractebel Energia SA (Tractebel Energia) is a Brazil-based company involved in the energy sector. The Company is engaged in the generation and sale of electric power generated by its assets or acquired through near and long-term agreements. In addition, it provides online customer services to its customers. Tractebel Energia operates power plants in the Brazilian states of Santa Catarina, Rio Grande do Sul, Parana, Sao Paulo, Mato Grosso do Sul, Mato Grosso, Goias, Ceara, Piaui, Minas Gerais, Tocantins and Maranhao. The Company generates energy through hydroelectric power plants, thermoelectric plants, small hydroelectric power plants, wind farms and biomass fired power plants. The Company is controlled by GDF SUEZ Energy Latin America Participacoes Ltda. Advisors' Opinion:

• [By Patricia Lara]

  The state-run water company�� market value rose to a record $11.1 billion at the end of last month, narrowing the gap to generator Tractebel Energia SA (TBLE3) to about $360.7 million, data compiled by Bloomberg show. That�� down from $1 billion at the end of last year and $3.89 billion at the start of 2012.

Best Shipping Companies To Watch In Right Now: ImmunoCellular Therapeutics Ltd (IMUC)

ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient�� own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies. The Company�� products include ICT-107, ICT-140, ICT-120, ICT-109 and DIAAD. ICT-107, the pipeline product, is a Phase II therapeutic dendritic cell (DC) vaccine for the treatment of glioblastoma multiforme (GBM), the common and lethal type of brain cancer. ICT-107 is designed to activate a patient�� immune system to target six different tumor-associated antigens. In February 2012, it acquired a world-wide license from the University of Pennsylvania and The John Hopkins University (JHU).

The Company in addition to ICT-107, is also developing other therapeutic DC vaccines: ICT-140 for ovarian cancer and ICT-121 for recurrent GBM. ICT-140 targets seven tumor-associated antigens expressed on ovarian cancer cells. ICT-107 is a DC vaccine that targets six different tumor-associated antigens that are found on patients��tumor cells; four of the six antigens are expressed on CSCs. The therapeutic vaccine is used subsequent to conventional therapy or concomitantly with chemotherapy in patients with newly diagnosed GBM. ICT-140 is a DC vaccine that targets seven different ovarian cancer antigens. ICT-121 is a DC vaccine that targets CD133 antigens; it has the potential to be a universal cancer vaccine because CD133 is widely expressed on CSCs from a majority of cancers. Data from this small study demonstrated that ICT-109 had a statistically ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets. The DIAAD (differential immunization for an! tigen and antibody discovery) platform it acquired from Molecular Discoveries utilizes immunological tolerization to accelerate the discovery of the molecular differences between diseased cells and their normal counterparts. The monoclonal antibodies produced by DIAAD provide the basis for the discovery and development of its potential diagnostic and therapeutic products.

The Company competes with Dendreon, Oncothyreon, Galena, Bavarian Nordic and Immunovaccine, Northwest Biotherapeutics, Prima Biomed, DCPrime, Roche/Genentech, Seattle Genetics, Bristol-Myers Squibb and Immunogen.

Advisors' Opinion:

• [By Smith On Stocks]

  Using my assumptions, the common of Agenus might be worth about $7.00 per share in early 2014 based on the royalties from the Glaxo vaccines and the net operating loss carry forward even if every other asset in the company were valued at zero. However, there may be substantial value in Agenus' internal vaccine programs in recurrent and newly diagnosed glioblastoma and the genital herpes vaccine. Based on a comparison to peer companies like Northwest Biotherapeutics (NWBO) and ImmunoCellular Therapeutics (IMUC), I believe that the internal programs at Agenus currently may be worth $150 million or $4.45 per share. Adding this to the value of the MAGE A-3 vaccine could produce a stock price of $11.00 in early 2014.

• [By Lauren Pollock]

  ImmunoCellular Therapeutics Ltd.(IMUC) said its leading product candidate, a dendritic cell-based vaccine for brain cancer, didn’t show a statistically significant advantage in overall survival in a Phase II study. In a research note, Maxim Group said it is pushing its EU approval date target to 2019 and lowered its estimate on the stock to $12 a share from $18 a share. The stock plunged 62% to $1.04 premarket.

• [By Wallace Witkowski]

  Shares of ImmunoCellular (IMUC) �jumped after the drug developer said data on a mid-stage brain cancer drug study were looking encouraging.

• [By Monica Gerson]

  ImmunoCellular Therapeutics (NYSE: IMUC) dropped 11.05% to $1.3699. ImmunoCellular's trailing-twelve-month ROE is -59.80%.

  Posted-In: market losersNews Movers & Shakers Intraday Update Markets

Best Shipping Companies To Watch In Right Now: Artesian Resources Corporation(ARTNA)

Artesian Resources Corporation, through its subsidiaries, provides water, wastewater, and engineering services on the Delmarva Peninsula. It distributes and sells water to residential, commercial, industrial, municipal, and utility customers in the states of Delaware, Maryland, and Pennsylvania. The company also offers water for public and private fire protection to customers in its service territories. In addition, it provides contract water and wastewater services, water and sewer service line protection plans, and wastewater management services, as well as design, construction, and engineering services. As of December 31, 2011, the company served approximately 78,600 metered water customers through 1,148 miles of transmission and distribution mains. Artesian Resources Corporation was founded in 1905 and is headquartered in Newark, Delaware.

Advisors' Opinion:

• [By Dividends4Life]

  Artesian Resources Corporation (ARTNA) provides water, wastewater, and other services on the Delmarva Peninsula. Sept. 17, the company increased its quarterly dividend 1.5% to $0.2088. The dividend is payable Nov. 22, 2013 to shareholders of record at the close of business on Nov. 8, 2013. The yield based on the new payout is 3.8%.

• [By Mike Deane]

  On Tuesday, Artesian Resources (ARTNA) declared a quarterly dividend of 20.88 cents per share, a 1.5% increase from the company’s previous quarterly payout.

  The Newark, Delaware-based water distribution company previously had a yearly payout of 82.28 cents, and will now pay 83.52 cents per year.

  The dividend will be payable on November 22nd, 2013 to all shareholders of record on November 8th, 2013. The ex-dividend date is November 6th, 2013.

  ARTNA shares were up 6 cents, or .27%, at Tuesday’s market close. The company’s stock is down just over 3% YTD.